7:30 AM ET
8-K
Capital Raise
Inovio Pharmaceuticals Capital Raise of $80.5M
INOVIO Pharmaceuticals entered into an underwriting agreement for a public offering of 58,747,235 shares of common stock and 12,681,337 pre-funded warrants. The underwriters fully exercised their option to purchase an additional 10,714,285 shares, bringing expected net proceeds to approximately $80.5 million. The capital will be used to support the company's development and commercialization of DNA medicines.
- Value
- $80.5M
- Counterparty
- Jefferies LLC and Piper Sandler & Co.